Validation of a mutant of the pore-forming toxin sticholysin-I for the construction of proteinase-activated immunotoxins

Protein Engineering, Design and Selection

Volumn 24, Issue 6, 2011, Pages 485-493

  Pentón, David ^a   Pérez Barzaga, Victor ^a   Díaz, Iscel ^a   Reytor, Mey L ^a   Campos, Javier ^b   Fando, Rafael ^b   Calvo, Loany ^c   Cilli, Eduardo M ^d   Morera, Vivian ^e   Castellanos Serra, Lila R ^e   Pazos, Fabiola ^a   Lanio, María E ^a   Álvarez, Carlos ^a   Pons, Tirso ^a   Tejuca, Mayra ^a  

^a UNIVERSITY OF HAVANA   (Cuba)

^b NATL CENTER FOR SCIENTIFIC RESEARCH   (Cuba)

^c CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

^d SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^e CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

Author keywords

actinoporin; immunotoxin; pore forming toxin; sea anemone cytolysin; sticholysins

Indexed keywords

ACTINOPORINS; IMMUNOTOXIN; PORE FORMING TOXINS; SEA ANEMONES; STICHOLYSINS;

AMINO ACIDS; CELL MEMBRANES; CYTOLOGY; METABOLITES; PEPTIDES; TUMORS;

TOXIC MATERIALS;

CYTOLYSIN; IMMUNOTOXIN; LIGAND; PEPTIDE; PORE FORMING CYTOTOXIC PROTEIN; STICHOLYSIN I; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE; MEMBRANE BINDING; MOLECULE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; SEA ANEMONE; TUMOR CELL; WILD TYPE;

ANIMALS; CELL MEMBRANE; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, ION EXCHANGE; DIMERIZATION; IMMUNOTOXINS; MODELS, MOLECULAR; MUTATION; ORGANIC CHEMICALS; PERFORIN; PORE FORMING CYTOTOXIC PROTEINS; PROTEIN BINDING; REPRODUCIBILITY OF RESULTS; SEA ANEMONES;

ACTINIARIA; STICHODACTYLA HELIANTHUS;

EID: 79956110384     PISSN: 17410126     EISSN: 17410134     Source Type: Journal    
DOI: 10.1093/protein/gzr002     Document Type: Article

References (39)

1. Al yahyaee,S.A.S. and Ellar,D.J. (1996) Bioconjug. Chem., 7, 451-460.
2. Anderluh,G., Barlic,A., Podlesek,Z., Macek,P., Pungercar,J., Gubensek,F., Zecchini,M., Dalla Serra,M. and Menestrina,G. (1999) Eur. J. Biochem., 263, 128-136.
3. Anderluh,G., Razpotnik,A., Podlesek,Z., Macek,P., Separovic,F. and Norton,R.S. (2005) J. Mol. Biol., 347, 27-39.
4. Athanasiadis,A., Anderluh,G., Macek,P. and Turk,D. (2001) Structure, 9, 341-346.
5. Avila,A.D., Calderon,C.F., Perez,R.M., Pons,C., Pereda,C.M. and Ortiz,A.R. (2007) Biol. Res., 40, 173-183.
6. Avila,A.D., de Acosta,M.C. and Lage,A. (1988) Int. J. Cancer, 42, 568-571.
7. Avila,A.D., de Acosta,M.C. and Lage,A. (1989) Int. J. Cancer, 43, 926-929.
8. Bakrac,B and Anderluh,G. (2010) Adv. Exp. Med. Biol., 677, 106-115.
9. Bakrac,B., Gutierrez-Aguirre,I., Podlesek,Z., Sonnen,A.F., Gilbert,R.J., Macek,P., Lakey,J.H. and Anderluh,G. (2008) J. Biol. Chem., 283, 18665-18677.
10. Bradford,M.M. (1976) Anal. Biochem., 72, 248-254.
11. Cohen,S., Cahan,R., Ben Dov,E., Nisnevitch,M., Zaritsky,A. and Firer,M.A. (2007) J. Biol. Chem., 282, 28301-28308.
12. Ellman,G.L. (1959) Arch. Biochem. Biophys., 82, 70-77.
13. Ghetie,V., Ghetie,M.A., Uhr,W.J. and Vitetta,E.S. (1988) J. Immunol. Methods, 112, 267-277.
14. Gurkan,C. and Ellar,D.J. (2003a) Protein Expr. Purif., 29, 103-116.
15. Gurkan,C. and Ellar,D.J. (2003b) Biotechnol. Appl. Biochem., 38, 25-33.
16. Hardy,E. and Castellanos-Serra,L.R. (2004) Anal. Biochem., 328, 1-13.
17. Hermanson,G.T. (1996) Bioconjugate Techniques. Academic Press, CA.
18. Hong,Q., Gutierrez-Aguirre,I., Barlic,A., et al. (2002) J. Biol. Chem., 277,41916-41924.
19. Huerta,V., Morera,V., Guanche,Y., et al. (2001) Toxicon, 39, 1253-1256.
20. Kyte,I. and Doolittle,R.F. (1982) J. Mol. Biol., 157, 105-132.
21. Laemmli,U.K. (1970) Nature, 227, 680-685.
22. Lanio,M.E., Morera,V., Alvarez,C., et al. (2001) Toxicon, 39, 187-194.
23. Mancheno,J.M., Martin-Benito,J., Martinez-Ripoll,M., Gavilanes,J.G. and Hermoso,J.A. (2003) Structure, 11, 1319-1328.
24. Marti-Renom,M.A., Stuart,A.C., Fiser,A., Sanchez,R., Melo,F. and Sali,A. (2000) Annu. Rev. Biophys. Biomol. Struct., 29, 291-325.
25. Masuho,Y., Hara,T. and Noguchi,T. (1979) Biochem. Biophys. Res. Commun., 90, 320-326.
26. Nagano,N., Ota,M. and Nishikawa,K. (1999) FEBS Lett., 458, 69-71.
27. Pazos,F., Valle,A., Martinez,D., et al. (2006) Toxicon, 48, 1083-1094.
28. Pederzolli,C., Belmonte,G., Dalla Serra,M., Macek,P. and Menestrina,G. (1995) Bioconjug. Chem, 6, 166-173.
29. Potrich,C., Tomazzolli,R., Dalla Serra,M., Anderluh,G., Malovrh,P., Macek,P., Menestrina,G. and Tejuca,M. (2005) Bioconjug. Chem., 16, 369-376.
30. Potrich,C., Viero,G., Tejuca,M., Anderluh,G., Macek,P. and Menestrina,G. (2000) Cytotoxic effect of equinatoxin II based immuno-toxins on human tumour cells. Med. Microbiol. Immunol., 189, 45.
31. Soletti,R.C., Alves,T., Vernal,J., Terenzi,H., Anderluh,G., Borges,H.L., Gabilan,N.H. and Moura-Neto,V. (2010) Anticancer Res., 30, 1209-1215.
32. Soletti,R.C., de Faria,G.P., Vernal,J., Terenzi,H., Anderluh,G., Borges,H.L., Moura-Neto,V. and Gabilan,N.H. (2008) Anticancer Drugs, 19, 517-525.
33. Tejuca,M., Anderluh,G. and Dalla,D.M. (2009) Toxicon, 54, 1206-1214.
34. Tejuca,M., Anderluh,G., Macek,P., et al. (1999) Int. J. Parasitol., 29, 489-498.
35. Tejuca,M., Diaz,I., Figueredo,R., et al. (2004) Int. Immunopharmacol., 4, 731-744.
36. Vriend,G. (1990) J. Mol. Graph., 8, 52-6, 29.
37. Wan,L., Zeng,L., Chen,L., Huang,Q., Li,S., Lu,Y., Li,Y., Cheng,J. and Lu,X. (2006) Protein Expr. Purif., 48, 307-313.
38. Yanisch-Perron,C., Vieira,J. and Messing,J. (1985) Gene, 33, 103-119.
39. Zeng,L., Wan,L., Chen,L., Li,S., Lu,Y., Huang,Q., Wang,L., Li,Y., Cheng,J. and Lu,X. (2006) Transplant. Proc., 38, 2151-2153.